Last reviewed · How we verify

NCT03818373

Respiratory Drive in Patients With Univentricular Congenital Heart Disease

Completed NA Last updated 4 January 2023
What this trial tests

NA trial testing polysomnography in Univentricular Heart in 32 participants. Completed in 7 July 2021.

Timeline
16 October 2017
Primary endpoint
7 July 2021
7 July 2021

Quick facts

Lead sponsorUniversity Hospital, Montpellier
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment32
Start date16 October 2017
Primary completion7 July 2021
Estimated completion7 July 2021
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

8 and older, any sex, with Univentricular Heart or Children, Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to evaluate the correlation between the respiratory control to hypercapnia at rest and the VE/VCO2 slope measured during cardiopulmonary exercise testing. The hypothesis is that patient with univentricular congenital heart disease have a increasing of respiratory drive like chronic heart failure. This increasing of respiratory drive could participate in the increasing of VE/VCO2 slope measured during cardiopulmonary exercise testing and in the genese of central apnea index during the sleep.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of COVID-19 disease on clinical research in pediatric and congenital cardiology.
    Pommier V, Abassi H, Lavastre K, Calderon J, et al · · 2022 · cited 3× · PMID 35523633 · DOI 10.1016/j.arcped.2022.03.004

Verify or expand the search:

Other trials of polysomnography

Trials testing the same drug.

Other recruiting trials for Univentricular Heart

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03818373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing